Application of screening principles to the reconstructed breast

Journal of Clinical Oncology

Volumn 28, Issue 1, 2010, Pages 173-180

  Zakhireh, Jennifer ^a   Fowble, Barbara ^a   Esserman, Laura J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; BREAST RECONSTRUCTION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; HUMAN; IMAGING SYSTEM; MASTECTOMY; MUTATIONAL ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; BREAST TUMOR; FEMALE; MAMMOGRAPHY; METHODOLOGY; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASTIC SURGERY; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMAPLASTY; MAMMOGRAPHY; MASTECTOMY; MUTATION; NEOPLASM RECURRENCE, LOCAL; SURGICAL FLAPS;

EID: 73949092400     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.21.7588     Document Type: Review

References (94)

1. Garwood ER, Moore D, Ewing C, et al: Total skin-sparing mastectomy: Complications and local recurrence rates in two cohorts of patients. Ann Surg 249:26-32, 2009
2. Katipamula R, Hoskin TL, Boughey JC, et al: Trends in mastectomy rates at the Mayo Clinic Rochester: Effect of surgical year and preoperative MRI. J Clin Oncol 26:8s, 2008 (suppl; abstr 509)
3. National Cancer Institute: Cancer Trends Progress Report: Update 2007. Bethesda, MD, National Institutes of Health, Department of Health and Human Services, 2007. http://progressreport.cancer.gov
4. Collins ED, Moore CP, Clay KF, et al: Can women with early-stage breast cancer make an informed decision for mastectomy? J Clin Oncol 27:519-525, 2009
5. Lee MC, Rogers K, Griffith K, et al: Determinants of breast conservation rates: Reasons for mastectomy at a comprehensive cancer center. Breast J 15:34-40, 2009
6. Christian CK, Niland J, Edge SB, et al: A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: A study of the National Comprehensive Cancer Network. Ann Surg 243:241-249, 2006
7. Simmons RM, Fish SK, Gayle L, et al: Local and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies. Ann Surg Oncol 6:676-681, 1999
8. Rosson GD, Singh NK, Ahuja N, et al: Multi-level analysis of the impact of community vs patient factors on access to immediate breast reconstruction following mastectomy in maryland. Arch Surg 143:1076-1081, 2008
9. Tuttle TM, Habermann EB, Grund EH, et al: Increasing use of contralateral prophylactic mastectomy for breast cancer patients: A trend toward more aggressive surgical treatment. J Clin Oncol 25:5203-5209, 2007
10. Tuttle TM, Jarosek S, Habermann EB, et al: Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 27:1362-1367, 2009
11. Surgery American Society of Plastic Surgeons: 2009 Report of the 2008 Statistics. Arlington Heights, IL, National Clearinghouse of Plastic Surgery Statistics, 2009
12. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002
13. Fisher B, Jeong JH, Anderson S, et al: Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347:567-575, 2002
14. Veronesi U, Cascinelli N, Mariani L, et al: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232, 2002
15. Kroll SS, Khoo A, Singletary SE, et al: Local recurrence risk after skin-sparing and conventional mastectomy: A 6-year follow-up. Plast Reconstr Surg 104:421-425, 1999
16. Carlson GW, Styblo TM, Lyles RH, et al: The use of skin sparing mastectomy in the treatment of breast cancer: The Emory experience. Surg Oncol 12:265-269, 2003
17. Vaughan A, Dietz JR, Aft R, et al: Scientific Presentation Award: Patterns of local breast cancer recurrence after skin-sparing mastectomy and immediate breast reconstruction. Am J Surg 194:438-443, 2007
18. Medina-Franco H, Vasconez LO, Fix RJ, et al: Factors associated with local recurrence after skinsparing mastectomy and immediate breast reconstruction for invasive breast cancer. Ann Surg 235: 814-819, 2002
19. Newman LA, Kuerer HM, Hunt KK, et al: Presentation, treatment, and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol 5:620-626, 1998
20. Wijayanayagam A, Kumar AS, Foster RD, et al: Optimizing the total skin-sparing mastectomy. Arch Surg 143:38-45, 2008; discussion 45
21. Petit JY, Veronesi U, Rey P, et al: Nipplesparing mastectomy: Risk of nipple-areolar recurrences in a series of 579 cases. Breast Cancer Res Treat 114:97-101, 2009
22. McCarthy CM, Pusic AL, Sclafani L, et al: Breast cancer recurrence following prosthetic, postmastectomy reconstruction: Incidence, detection, and treatment. Plast Reconstr Surg 121:381-388, 2008
23. Langstein HN, Cheng MH, Singletary SE, et al: Breast cancer recurrence after immediate reconstruction: Patterns and significance. Plast Reconstr Surg 111:712-720, 2003; discussion 721-722
24. Noone RB, Frazier TG, Noone GC, et al: Recurrence of breast carcinoma following immediate reconstruction: A 13-year review. Plast Reconstr Surg 93:96-106, 1994; discussion 107-108
25. Howard MA, Polo K, Pusic AL, et al: Breast cancer local recurrence after mastectomy and TRAM flap reconstruction: Incidence and treatment options. Plast Reconstr Surg 117:1381-1386, 2006
26. Slavin SA, Schnitt SJ, Duda RB, et al: Skinsparing mastectomy and immediate reconstruction: Oncologic risks and aesthetic results in patients with early-stage breast cancer. Plast Reconstr Surg 102:49-62, 1998
27. Georgiade GS, Riefkohl R, Cox E, et al: Longterm clinical outcome of immediate reconstruction after mastectomy. Plast Reconstr Surg 76:415-420, 1985
28. Johnson CH, van Heerden JA, Donohue JH, et al: Oncological aspects of immediate breast reconstruction following mastectomy for malignancy. Arch Surg 124:819-823, 1989; discussion 823-824
29. Buchanan CL, Dorn PL, Fey J, et al: Locoregional recurrence after mastectomy: Incidence and outcomes. J Am Coll Surg 203:469-474, 2006
30. Taghian A, Jeong JH, Mamounas E, et al: Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: Results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 22:4247-4254, 2004
31. Khatcheressian JL, Wolff AC, Smith TJ, et al: American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24:5091-5097, 2006
32. Chagpar A, Langstein HN, Kronowitz SJ, et al: Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction. Am J Surg 187:164-169, 2004
33. Andermann A, Blancquaert I, Beauchamp S, et al: Revisiting Wilson and Jungner in the genomic age: A review of screening criteria over the past 40 years. Bull World Health Organ 86:317-319, 2008
34. Bjurstam N, Bjorneld L, Warwick J, et al: The Gothenburg Breast Screening Trial. Cancer 97:2387-2396, 2003
35. Nyström L, Andersson I, Bjurstam N, et al: Long-term effects of mammography screening: Updated overview of the Swedish randomised trials. Lancet 359:909-919, 2002
36. Nyström L, Rutqvist LE, Wall S, et al: Breast cancer screening with mammography: Overview of Swedish randomised trials. Lancet 341:973-978, 1993
37. Rijnsburger AJ, van Oortmarssen GJ, Boer R, et al: Mammography benefit in the Canadian National Breast Screening Study-2: a model evaluation. Int J Cancer 110:756-762, 2004
38. Shapiro S: Periodic screening for breast cancer: The HIP Randomized Controlled Trial - Health Insurance Plan. J Natl Cancer Inst Monogr 27-30, 1997
39. Andersson I, Aspegren K, Janzon L, et al: Mammographic screening and mortality from breast cancer: The Malmo mammographic screening trial. BMJ 297:943-948, 1988
40. Tabar L, Fagerberg CJ, Gad A, et al: Reduction in mortality from breast cancer after mass screening with mammography: Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1:829-832, 1985
41. Alexander FE, Anderson TJ, Brown HK, et al: 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 353: 1903-1908, 1999
42. Ernster VL, Ballard-Barbash R, Barlow WE, et al: Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94:1546-1554, 2002
43. Kerlikowske K: The mammogram that cried Wolfe. N Engl J Med 356:297-300, 2007
44. Carney PA, Miglioretti DL, Yankaskas BC, et al: Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138:168-175, 2003
45. Boyd NF, Guo H, Martin LJ, et al: Mammographic density and the risk and detection of breast cancer. N Engl J Med 356:227-236, 2007
46. Heywang SH, Wolf A, Pruss E, et al: MR imaging of the breast with Gd-DTPA: Use and limitations. Radiology 171:95-103, 1989
47. Kaiser WA, Zeitler E: MR imaging of the breast: Fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 170: 681-686, 1989
48. Revel D, Brasch RC, Paajanen H, et al: Gd-DTPA contrast enhancement and tissue differentiation in MR imaging of experimental breast carcinoma. Radiology 158:319-323, 1986
49. Pierce WB, Harms SE, Flamig DP, et al: Three-dimensional gadolinium-enhanced MR imaging of the breast: Pulse sequence with fat suppression and magnetization transfer contrast - Work in progress. Radiology 181:757-763, 1991
50. Stack JP, Redmond OM, Codd MB, et al: Breast disease: Tissue characterization with Gd-DTPA enhancement profiles. Radiology 174:491-494, 1990
51. Saslow D, Boetes C, Burke W, et al: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75-89, 2007
52. Kriege M, Brekelmans CT, Boetes C, et al: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427-437, 2004
53. Warner E, Plewes DB, Hill KA, et al: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292: 1317-1325, 2004
54. Arpino G, Laucirica R, Elledge RM: Premalignant and in situ breast disease: Biology and clinical implications. Ann Intern Med 143:446-457, 2005
55. Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146-151, 1985
56. Page DL, Dupont WD, Rogers LW, et al: Atypical hyperplastic lesions of the female breast: A long-term follow-up study. Cancer 55:2698-2708, 1985
57. Hartmann LC, Sellers TA, Frost MH, et al: Benign breast disease and the risk of breast cancer. N Engl J Med 353:229-237, 2005
58. Byrne C, Schairer C, Wolfe J, et al: Mammographic features and breast cancer risk: Effects with time, age, and menopause status. J Natl Cancer Inst 87:1622-1629, 1995
59. Boyd NF, Byng JW, Jong RA, et al: Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87:670-675, 1995
60. Ursin G, Hovanessian-Larsen L, Parisky YR, et al: Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res 7:R605-R608, 2005
61. Gail MH, Brinton LA, Byar DP, et al: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886, 1989
62. Tice JA, Cummings SR, Ziv E, et al: Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat 94:115-122, 2005
63. Zakhireh J, Gomez R, Esserman L: Converting evidence to practice: A guide for the clinical application of MRI for the screening and management of breast cancer. Eur J Cancer 44:2742-2752, 2008
64. Barnsley GP, Grunfeld E, Coyle D, et al: Surveillance mammography following the treatment of primary breast cancer with breast reconstruction: A systematic review. Plast Reconstr Surg 120:1125-1132, 2007
65. Fersis N, Hoenig A, Relakis K, et al: Skinsparing mastectomy and immediate breast reconstruction: Incidence of recurrence in patients with invasive breast cancer. Breast 13:488-493, 2004
66. Ross AC, Rusnak CH, Hill MK, et al: An analysis of breast cancer surgery after free transverse rectus abdominis myocutaneous (TRAM) flap reconstruction. Am J Surg 179:412-416, 2000
67. Shaikh N, LaTrenta G, Swistel A, et al: Detection of recurrent breast cancer after TRAM flap reconstruction. Ann Plast Surg 47:602-607, 2001
68. Lee JM, Georgian-Smith D, Gazelle GS, et al: Detecting nonpalpable recurrent breast cancer: The role of routine mammographic screening of transverse rectus abdominis myocutaneous flap reconstructions. Radiology 248:398-405, 2008
69. Helvie MA, Bailey JE, Roubidoux MA, et al: Mammographic screening of TRAM flap breast reconstructions for detection of nonpalpable recurrent cancer. Radiology 224:211-216, 2002
70. Wallgren A, Bonetti M, Gelber RD, et al: Risk factors for locoregional recurrence among breast cancer patients: Results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol 21:1205-1213, 2003
71. Recht A, Gray R, Davidson NE, et al: Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17:1689-1700, 1999
72. Buchholz TA, Tucker SL, Masullo L, et al: Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol 20:17-23, 2002
73. McGuire SE, Gonzalez-Angulo AM, Huang EH, et al: Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 68:1004-1009, 2007
74. Huang EH, Tucker SL, Strom EA, et al: Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol 22: 4691-4699, 2004
75. Recht A, Edge SB, Solin LJ, et al: Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1539-1569, 2001
76. Harris JR, Halpin-Murphy P, McNeese M, et al: Consensus Statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys 44:989-990, 1999
77. Jagsi R, Abrahamse P, Morrow M, et al: Postmastectomy radiotherapy for breast cancer: Patterns, correlates, communication, and insights into the decision process. Cancer 115:1185-1193, 2009
78. Nuyten DS, Kreike B, Hart AA, et al: Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 8:R62, 2006
79. Cheng SH, Horng CF, West M, et al: Genomic prediction of locoregional recurrence after mastectomy in breast cancer. J Clin Oncol 24:4594-4602, 2006
80. Mamounas E, Tang G, Bryant J, et al: Association between the 21-gene recurrence score assay (RS) and risk of locoregional failure in node-negative, ER-positive breast cancer: Results from NSABP B-14 and NSABP B-20. Presented at 28th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 8-11, 2005
81. van de Vijver MJ, He YD, van't Veer LJ, et al: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009, 2002
82. van't Veer LJ, Dai H, van de Vijver MJ, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536, 2002
83. Paik S, Shak S, Tang G, et al: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817-2826, 2004
84. Skaane P: The additional value of US to mammography in the diagnosis of breast cancer. A prospective study. Acta Radiol 40:486-490, 1999
85. Gisvold JJ, Karsell PR, Reese EC: Clinical evaluation of computerized tomographic mammography. Mayo Clin Proc 52:181-185, 1977
86. Gisvold JJ, Reese DF, Karsell PR: Computed tomographic mammography (CTM). AJR Am J Roentgenol 133:1143-1149, 1979
87. Chen B, Ning R: Cone-beam volume CT breast imaging: Feasibility study. Med Phys 29:755-770, 2002
88. Boone JM, Kwan AL, Yang K, et al: Computed tomography for imaging the breast. J Mammary Gland Biol Neoplasia 11:103-111, 2006
89. Hartmann LC, Schaid DJ, Woods JE, et al: Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340:77-84, 1999
90. Zakaria S, Degnim AC: Prophylactic mastectomy. Surg Clin North Am 87:317-331, vi, 2007
91. van Sprundel TC, Schmidt MK, Rookus MA, et al: Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer 93:287-292, 2005
92. Antoniou A, Pharoah PD, Narod S, et al: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 72:1117-1130, 2003
93. King MC, Marks JH, Mandell JB: Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643-646, 2003
94. Ford D, Easton DF, Stratton M, et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families: The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676-689, 1998